American Family Children's Hospital
SHARE TEXT
David R. Andes, MD close
Tvg6uXVvHQc
David R. Andes, MD
 


For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

David R. Andes, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Andes’ clinical interests include general infectious diseases, transplant infectious diseases, mycology, antimicrobial pharmacokinetics and pharmacodynamics. 

Specialties

Infectious Diseases

Travel Medicine

UW Health Clinics

University Hospital
(608) 263-0946 | (800) 323-8942 | Map
University Hospital
(608) 890-6167 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)
Veterans Hospital - Wm. S. Middleton Memorial, UnityPoint Health - Meriter (secondary)

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Infectious Diseases
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Missouri, 1992

Awards/Honors

Best Doctors® in America 2015

Best Doctors® in America 2014

Best Doctors® in America 2013

Madison Magazine Top Docs 2012

 


Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

The overriding themes of our research programs are to advance our understanding of antibacterial and antifungal activity and drug resistance, and to identify new antimicrobial drug treatment strategies and drug targets.


PubMed Articles
Shekhar-Guturja T Gunaherath GM Wijeratne EM Lambert JP Averette AF Lee SC Kim T Bahn YS Tripodi F Ammar R Döhl K Niewola-Staszkowska K Schmitt L Loewith RJ Roth FP Sanglard D Andes D Nislow C Coccetti P Gingras AC Heitman J Gunatilaka AA Cowen LE . Dual action antifungal small molecule modulates multidrug efflux and TOR signaling. Nat Chem Biol. 2016 Oct;12(10):867-75
[PubMed ID: 27571477]
Winter MB Salcedo EC Lohse MB Hartooni N Gulati M Sanchez H Takagi J Hube B Andes DR Johnson AD Craik CS Nobile CJ . Global Identification of Biofilm-Specific Proteolysis in Candida albicans. MBio. 2016 Sep 13;7(5)
[PubMed ID: 27624133]
Dalal CK Zuleta IA Mitchell KF Andes DR El-Samad H Johnson AD . Transcriptional rewiring over evolutionary timescales changes quantitative and qualitative properties of gene expression. Elife. 2016 Sep 10;5
[PubMed ID: 27614020]
Mitchell KF Zarnowski R Andes DR . Fungal Super Glue: The Biofilm Matrix and Its Composition, Assembly, and Functions. PLoS Pathog. 2016 Sep;12(9):e1005828
[PubMed ID: 27685086]
Lepak AJ Andes DR . In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model. Antimicrob Agents Chemother. 2016 Aug;60(8):4764-9
[PubMed ID: 27216072]
Pappas PG Kauffman CA Andes DR . Reply to Simon and to Eljaaly and Nix. Clin Infect Dis. 2016 Jul 15;63(2):287-8
[PubMed ID: 27114379]
Khandelwal NK Kaemmer P Förster TM Singh A Coste AT Andes DR Hube B Sanglard D Chauhan N Kaur R d'Enfert C Mondal AK Prasad R . Pleiotropic effects of the vacuolar ABC transporter MLT1 of Candida albicans on cell function and virulence. Biochem J. 2016 Jun 1;473(11):1537-52
[PubMed ID: 27026051]
Andes D Azie N Yang H Harrington R Kelley C Tan RD Wu EQ Franks B Kristy R Lee E Khandelwal N Spalding J . Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients. Antimicrob Agents Chemother. 2016 Jun;60(6):3398-406
[PubMed ID: 27001815]
Nett JE Cabezas-Olcoz J Marchillo K Mosher DF Andes DR . Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms. Antimicrob Agents Chemother. 2016 May;60(5):3152-5
[PubMed ID: 26902759]
Nett JE Andes DR . Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect Dis Clin North Am. 2016 Mar;30(1):51-83
[PubMed ID: 26739608]
Pappas PG Kauffman CA Andes DR Clancy CJ Marr KA Ostrosky-Zeichner L Reboli AC Schuster MG Vazquez JA Walsh TJ Zaoutis TE Sobel JD . Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):409-17
[PubMed ID: 26810419]
Pappas PG Kauffman CA Andes DR Clancy CJ Marr KA Ostrosky-Zeichner L Reboli AC Schuster MG Vazquez JA Walsh TJ Zaoutis TE Sobel JD . Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-50
[PubMed ID: 26679628]
Raman N Marchillo K Lee MR Rodríguez López AL Andes DR Palecek SP Lynn DM . Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection. ACS Biomater Sci Eng. 2016 Jan 11;2(1):112-121
[PubMed ID: 26807439]
Mitchell KF Zarnowski R Andes DR . The Extracellular Matrix of Fungal Biofilms. Adv Exp Med Biol. 2016;931:21-35
[PubMed ID: 27271680]
Walsh TJ Azie N Andes DR . Development of New Strategies for Echinocandins: Progress in Translational Research. Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S601-3
[PubMed ID: 26567276]
Nett JE Zarnowski R Cabezas-Olcoz J Brooks EG Bernhardt J Marchillo K Mosher DF Andes DR . Host contributions to construction of three device-associated Candida albicans biofilms. Infect Immun. 2015 Dec;83(12):4630-8
[PubMed ID: 26371129]
Sidoryk K Świtalska M Jaromin A Cmoch P Bujak I Kaczmarska M Wietrzyk J Dominguez EG Żarnowski R Andes DR Bańkowski K Cybulski M Kaczmarek Ł . The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents. Eur J Med Chem. 2015 Nov 13;105:208-19
[PubMed ID: 26496013]
Lepak AJ Parhi A Madison M Marchillo K VanHecker J Andes DR . In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model. Antimicrob Agents Chemother. 2015 Oct;59(10):6568-74
[PubMed ID: 26259789]
Zhang F Adnani N Vazquez-Rivera E Braun DR Tonelli M Andes DR Bugni TS . Application of 3D NMR for Structure Determination of Peptide Natural Products. J Org Chem. 2015 Sep 4;80(17):8713-9
[PubMed ID: 26273993]
Vergidis P Avery RK Wheat LJ Dotson JL Assi MA Antoun SA Hamoud KA Burdette SD Freifeld AG McKinsey DS Money ME Myint T Andes DR Hoey CA Kaul DA Dickter JK Liebers DE Miller RA Muth WE Prakash V Steiner FT Walker RC Hage CA . Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 1;61(3):409-17
[PubMed ID: 25870331]